eIF2beta Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-eIF2beta antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | eIF2beta |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: eIF2beta Polyclonal Antibody detects endogenous levels of eIF2beta protein. Eukaryotic translation initiation factor 2 (EIF-2) functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA and binding to a 40S ribosomal subunit. EIF-2 is composed of three subunits, alpha, beta, and gamma, with the protein encoded by EIF2S2 (eukaryotic translation initiation factor 2 subunit beta) representing the beta subunit. The beta subunit catalyzes the exchange of GDP for GTP, which recycles the EIF-2 complex for another round of initiation. Multiple transcript variants encoding different isoforms have been found for EIF2S2. |
| Immunogen | Immunogen: Synthesized peptide derived from human eIF2beta around the non-phosphorylation site of S67 |
| Other Names | [Rabbit eIF2beta; EIF2S2; EIF2B; Eukaryotic translation initiation factor 2 subunit 2; Eukaryotic translation initiation factor 2 subunit beta; eIF-2-beta] |
| Gene, Accession # | [eIF2beta], Gene ID: 8894, NCBI: NP_003899.2, UniProt: P20042 |
| Catalog # | MBS9707525 |
| Price | $130, $220, $325 |
| Order / More Info | eIF2beta Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies